Additional Product Features
Edition Number5
Intended AudienceScholarly & Professional
Dewey Edition23
Reviews'The opportunity to review and comment on Stahl's Essential Psychopharmacology, 5th edition, is truly a pleasure. The depth and comprehension of this edition reads like a fresh view of everything we would want to know in the area of psychopharmacology, including the integration of basic and clinical neuroscience information. The clarity as a teaching tool for any level of education and sophistication is remarkable, just as is the ease of reading and enjoying the unique set of figures and tables. The book represents a departure from the usual fare that we are offered as we delve into the mysteries of our body. In short, this 5th edition is not a simple reworking of earlier editions but really a brand new view. It represents a model for the way that we should cover other areas of neuroscience.' Ellen Frank, Ph.D., Distinguished Professor Emeritus of Psychiatry, University of Pittsburgh School of Medicine, 'Psychopharmacology has always benefitted from a virtuous cycle of science informing clinical practice and clinical questions driving the science, an approach now often called 'Translational Medicine'. However, this approach does present challenges for those who wish to learn about or keep up with such a diverse, rich, and rapidly evolving knowledge base. Essential Psychopharmacology admirably meets these needs covering all relevant fields of Psychopharmacology in an expertly informed and accessible way. Previous editions have established Essential Psychopharmacology as a vital introductory and reference text for the students and practitioners of psychopharmacology and for all scientists with an interest in the field. The latest edition follows its predecessors and will undoubtedly be a vital resource for all those interested in this fascinating discipline.' Allan Young, Chair of Mood Disorders, Director of the Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College Londonchology and Neuroscience, King's College Londonchology and Neuroscience, King's College Londonchology and Neuroscience, King's College London
IllustratedYes
Dewey Decimal616.89/18
Edition DescriptionRevised edition
Table Of ContentPreface to the Fifth Edition; CME Information; 1. Chemical Neurotransmission; 2. Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug Action; 3. Ion Channels as Targets of Psychopharmacological Drug Action; 4. Psychosis, Schizophrenia and the Neurotransmitter Networks Dopamine, Serotonin and Glutamate; 5. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood and Beyond: So-Called 'Antipsychotics'; 6. Mood Disorders and the Neurotransmitter Networks Norepinephrine and Gamma Amino Butyric Acid (Gaba); 7. Treatments for Mood Disorders: So-Called 'Antidepressants' and 'Mood Stabilizers'; 8. Anxiety, Trauma and Treatment; 9. Chronic Pain and its Treatment; 10. Disorders of Sleep and Wakefulness and their Treatment: Neurotransmitter Networks for Histamine and Orexin; 11. Attention Deficit Hyperactivity Disorder and its Treatment; 12. Dementia: Causes, Symptomatic Treatments and the Neurotransmitter Network Acetylcholine; 13. Impulsivity, Compulsivity and Addiction; Suggested Reading and Selected References; Index.
SynopsisThe fully updated fifth edition continues to present the fundamentals of psychopharmacology in a simplified and readily readable form, emphasizing current formulations of disease and drug mechanisms. The organization of information applies the principles of programmed learning, namely repetition and interaction, which enhances retention., Long established as the preeminent source in its field, the eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! With its use of icons and figures that form Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. Every aspect of the book has been updated, with the clarity of explanation that only Dr Stahl can bring. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, fourteen new uses for older drugs and eighteen brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy.
LC Classification NumberRM315